Disease Detection, Prevention, and Treatment

Phage infecting bacteria close-up

Leveraging Bacteriophages in Vaccine Development

Leveraging Bacteriophages in Vaccine Development 768 432 IEEE Pulse

It’s a bacteriophage’s world; we’re just living in it Bacteriophages, or phages for short, are viruses that specifically infect bacterial cells. Their name is derived from Greek for “bacteria eater”…

read more
Protecting world from Coronavirus COVID 19

Has COVID Taught Us to be Better Prepared for the Next Pandemic?

Has COVID Taught Us to be Better Prepared for the Next Pandemic? 768 432 IEEE Pulse

Although it is too soon to say we have reached the end of the COVID-19 pandemic, scientists, politicians, and ordinary citizens are looking to the future and asking the same…

read more

Looking Disease in the Eye

Author(s): Jim Banks
Looking Disease in the Eye 2383 1258 IEEE Pulse
From eye disease to neurological conditions, new technologies are making earlier diagnosis and better patient outcomes a reality by investigating the eye. read more

Innovative Vaccines to Fight COVID-19, Other Viruses

Author(s): Leslie Mertz
Innovative Vaccines to Fight COVID-19, Other Viruses 2257 1328 IEEE Pulse
COVID-19 added urgency to the quest for the development of new vaccines, and academic researchers and biotechnology companies responded by capitalizing on already-in-the-pipeline advances and swiftly transitioning products from the lab to the clinic. Their efforts reaped rewards. According to a U.S. Department of Health and Human Services analysis, the COVID vaccines delivered in the USA from January to May 2021 resulted in 39,000 fewer deaths and 107,000 fewer hospitalizations, and prevented another 265,000 cases among Medicare recipients alone. read more

Harnessing Another Tool for Treating Brain Cancer

Author(s): Cynthia Weber
Harnessing Another Tool for Treating Brain Cancer 1000 596 IEEE Pulse
In the United States alone, an estimated 700,000 people have been diagnosed and are living with a brain tumor, and it is estimated that approximately 84,000 people will receive a tumor diagnosis in 2021 [1]. Fortunately, the majority of these tumors will be benign; on average only 30% of all brain tumors are malignant. For patients with malignant tumors, the current five-year survival rate is 36% with an average 31% ten-year survival rate [2], but for those diagnosed with glioblastoma (GBM)—one of the most deadly and treatment-resistant cancers—the patient survival rate falls to a low 7.2% and the median life-span after diagnosis is only eight months. GBM is the most common primary malignant brain tumor, even as an increasing numbers of cancer patients are diagnosed with brain metastases (secondary brain tumors), where the cancer has traveled to the brain from another part of the body. read more

Probing the Future of Psychedelics for Mental Health

Author(s): Summer Allen
Probing the Future of Psychedelics for Mental Health 1000 822 IEEE Pulse
Mounting evidence suggests that psychedelics may be useful for treating a range of different neuropsychiatric conditions that currently have limited treatment options. On May 4–6, 2021, leaders from academia and industry discussed a variety of issues related to the development and adoption of psychedelic drugs for different conditions during the virtual Psychedelic Therapeutics and Drug Development Conference. Selected topics from the conference are presented below. read more

Targeting the Gut to Treat the Brain

Author(s): Mary Bates
Targeting the Gut to Treat the Brain 1000 563 IEEE Pulse
Only ten years ago, the idea that bacteria in your gut could affect your brain and behavior was seen as a fringe theory. But today, it is well-established that the trillions of microbes in the gastrointestinal tract—collectively known as the gut microbiome—profoundly influence the brain. Now, researchers are working to harness the power of the gut microbiome to develop new treatments for brain disorders. read more

The Search for a Drug to End Alzheimer’s

Author(s): Sarah Campbell
The Search for a Drug to End Alzheimer’s 2139 1402 IEEE Pulse
On November 6, 2020, researchers who have been laboring to find a drug that will treat Alzheimer’s disease (AD) dialed in to a public meeting of the U.S. Food and Drug Administration’s (FDA) Peripheral and Central Nervous System Drugs Advisory Committee. The committee would review drug trials of Biogen’s aducanumab, and conclude with a vote on the drug’s safety and efficacy in treating AD. The independent advisors’ decision wouldn’t be the official one for aducanumab, but their vote usually mirrors the final FDA decision. read more

From Face-to-Face to FaceTime

Author(s): Sarah Campbell
From Face-to-Face to FaceTime 2322 1290 IEEE Pulse
In a Jetsons episode from 60 years ago, Elroy, the youngest Jetson, tries to get out of taking a space calculus test at school by telling his mom he’s sick. “I think I have Venus Virus,” he says. His mom doubts him, but summons a doctor anyway. read more